logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
      • IPED2015 Clinical Program
      • IP2018 Clinical Program
      • IPTN2021 Clinical Program
      • IP2017 Program* (preclinical)
      • IP2016 Program* (preclinical)
    • Technology & Therapeutic Areas
      • Erectile Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Investment case
    • Reports and Presentations
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Annual General Meeting 2022

May 24, 2022

The annual general meeting of Initiator Pharma A/S (the “Company”) was held on Tuesday, 24 May 2022, at 10:00 AM CEST at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark.

Documents

  • Minutes from the Annual General Meeting
    May 24, 2022 Danish
    Download pdf
  • Press release – Initiator Pharma – Notice of Annual general meeting
    April 27, 2022 English
    Download pdf
  • Report – Annual report 2021
    April 27, 2022 English
    Download pdf
  • Remuneration Report 2021
    April 27, 2022 English
    Download pdf
  • Appendix 1 – Remuneration Policy
    April 27, 2022 English
    Download pdf
  • Appendix 2 – Updated articles of association
    April 27, 2022 English
    Download pdf
  • Appendix 3 – LTI2022 – Management
    April 27, 2022 English
    Download pdf
  • Appendix 5 – IP Proxy and vote form
    April 27, 2022 English
    Download pdf
  • Appendix 4 – LTI2022 – Board of Directors
    April 27, 2022 English
    Download pdf
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
    • IPED2015 Clinical Program
    • IP2018 Clinical Program
    • IPTN2021 Clinical Program
    • IP2017 Program* (preclinical)
    • IP2016 Program* (preclinical)
  • Technology & Therapeutic Areas
    • Erectile Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Investment case
  • Reports and Presentations
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact

Share

Read more
  • Cookies
  • Privacy